Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$448M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$248M |
| 3 |
AGN
Allergan Inc
AGN
|
+$240M |
| 4 |
Apple
AAPL
|
+$223M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$677M |
| 2 |
Intuitive Surgical
ISRG
|
+$501M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$476M |
| 4 |
Crown Castle
CCI
|
+$365M |
| 5 |
Ralph Lauren
RL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.54% |
| 2 | Consumer Discretionary | 15.06% |
| 3 | Technology | 11.56% |
| 4 | Energy | 11.06% |
| 5 | Communication Services | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Oxford Industries
OXM
$572M
| $324K | ﹤0.01% |
+4,760
| New | +$315K |
|
677
Green Dot
GDOT
$760M
| $319K | ﹤0.01% |
+12,109
| New | +$280K |
|
678
Charles River Laboratories
CRL
$13.9B
| $279K | ﹤0.01% |
+6,037
| New | +$277K |
|
679
SiriusXM
SIRI
$9.62B
| $55K | ﹤0.01% |
1,412
-550
| -28% | -$20.5K |
|
680
Baxter International
BAX
$13.5B
| – | – |
-971,637
| Closed | -$36.6M |
|
681
Blackstone Mortgage Trust
BXMT
$2.31B
| – | – |
-219,359
| Closed | -$5.42M |
|
682
Cardinal Health
CAH
$54.6B
| – | – |
-14,547
| Closed | -$687K |
|
683
Caterpillar
CAT
$368B
| – | – |
-33,565
| Closed | -$2.77M |
|
684
CF Industries
CF
$19B
| – | – |
-28,700
| Closed | -$984K |
|
685
Colgate-Palmolive
CL
$72.3B
| – | – |
-8,351
| Closed | -$478K |
|
686
Clearwater Paper
CLW
$336M
| – | – |
-21,848
| Closed | -$1.03M |
|
687
Compass Minerals
CMP
$1.03B
| – | – |
-402,441
| Closed | -$34M |
|
688
Carpenter Technology
CRS
$23.6B
| – | – |
-7,643
| Closed | -$344K |
|
689
Carlisle Companies
CSL
$14.2B
| – | – |
-6,964
| Closed | -$434K |
|
690
Healthpeak Properties
DOC
$14.5B
| – | – |
-55,389
| Closed | -$2.29M |
|
691
DaVita
DVA
$11.5B
| – | – |
-2,826,928
| Closed | -$171M |
|
692
ENI
E
$76.1B
| – | – |
-412,650
| Closed | -$16.9M |
|
693
Equifax
EFX
$22.8B
| – | – |
-4,702
| Closed | -$277K |
|
694
Elevance Health
ELV
$85.5B
| – | – |
-37,519
| Closed | -$3.07M |
|
|
VMRK
695
Vivmark Residential
VMRK
$26.1B
| – | – |
-44,654
| Closed | -$2.59M |
|
696
Eaton
ETN
$156B
| – | – |
-47,918
| Closed | -$3.15M |
|
697
CALL
Edwards Lifesciences
EW
$52B
| – | – |
-1,800,000
| Closed | -$20.2M |
|
698
CALL
Gilead Sciences
GILD
$181B
| – | – |
-20,000
| Closed | -$1.02M |
|
699
Intrepid Potash
IPI
$506M
| – | – |
-165,013
| Closed | -$31.4M |
|
|
700
Intuitive Surgical
ISRG
$132B
| – | – |
-8,904,690
| Closed | -$501M |
|
Similar funds
Jennison Associates's Q3 2013 Portfolio in Review
As of Q3 2013, Jennison Associates held 756 positions worth $95.4B, up 7.3% from $88.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates withdrew a net $3.56B in Q3 2013, closing 76 positions and reducing 326 holdings. Its most notable exit was Intuitive Surgical, an estimated $501M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Jennison Associates opened a new position in Under Armour worth $157M.
- Jennison Associates's largest Q3 2013 buy was Under Armour: 7,886,544 shares worth $157M.
- Jennison Associates added most to Capri Holdings in Q3 2013, an estimated $448M increase.
- Jennison Associates's biggest Q3 2013 reduction was IBM, cutting an estimated $677M.
- Jennison Associates fully exited Intuitive Surgical in Q3 2013, selling an estimated $501M.
- Jennison Associates's ten largest holdings make up 19% of its $95.4B portfolio in Q3 2013.
- Jennison Associates opened 84 new positions and closed 76 in Q3 2013.
- Jennison Associates's portfolio value rose 7.3% quarter-over-quarter to $95.4B.
Based on Jennison Associates's 13F filing for Q3 2013, filed 13 Nov 2013.